Wada, Naoki, et al. “Elevated Serum Growth Differentiation Factor 15 Levels As a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study”. Journal of Clinical Medicine Research, vol. 16, no. 10, Oct. 2024, pp. 503-8, https://doi.org/10.14740/jocmr6031.